Connect with us

Hi, what are you looking for?

Jewish Business News


Israeli therapeutics company Kamada files preliminary prospectus with SEC

/ By Clive Minchom /

Pharmaceutical company Kamada Ltd. (TASE: KMDA) filed a preliminary prospectus for an offering on Nasdaq with the US Securities and Exchange kamadaCommission (SEC) on Friday. Morgan Stanley & Co. LLC and Jefferies LLC are the underwriters. No pricing terms were disclosed.
The preliminary prospectus has not yet come into effect, and it is not binding on the company to hold an offering.

Earlier this month, Kamada guided for $74 million revenue in 2013, up from $73 million in 2012.

Kamada, which produces plasma-derived protein therapeutics, filed on Thursday with the SEC to raise up to $69 million in an initial public offering. The company’s shares are already listed on the Tel Aviv Stock Exchange under the symbol KMDA.




You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.